Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC.

David PlanchardPasi A JänneYing ChengJames C-H YangNoriko YanagitaniSang-We KimShunichi SugawaraYan YuYun FanSarayut L GeaterKonstantin LaktionovChee K LeeNatalia ValdiviezoSamreen AhmedJean-Marc MaurelIgor AndrasinaJonathan Wade GoldmanDana GhiorghiuYuri RukazenkovAlex ToddKunihiko Kobayashinull null

Published in: The New England journal of medicine (2023)

-mutated advanced NSCLC. (Funded by AstraZeneca; FLAURA2 ClinicalTrials.gov number, NCT04035486.).

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
epidermal growth factor receptor
brain metastases
tyrosine kinase
locally advanced
squamous cell carcinoma